The FDA has approved two immunotherapy combination therapies for adults with muscle-invasive bladder cancer. Pembrolizumab ...
The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. The agency greenlit Merck's Keytruda and its ...
Men had a higher likelihood than women for late-stage diagnosis of 20 different types of cancer, data from a national ...
The platform, including the assay, specimen collection kit, and associated software, underwent a comprehensive review including evidence of analytical and clinical validity.
OSLO, Norway, June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The ...
IND clearance allows initiation of a Q4 2026 phase 1 NMIBC study evaluating intravesical UGN-501 safety, tolerability, and administration feasibility. Recurrence remains common in NMIBC, especially ...
The Hearty Soul on MSN
What are the symptoms of prostate cancer and what should you check for?
Know the 8 prostate cancer symptoms to watch for, from urinary changes to bone pain, plus who is most at risk and when to get screened. The post 8 Prostate Cancer Symptoms Every Man Should Know About ...
The Galleri MCED test is intended to detect more than 50 cancers at an early stage, and in doing so, improve patient outcomes while significantly reducing treatment costs -- late-stage cancers (III ...
Please provide your email address to receive an email when new articles are posted on . Men with taller height, higher body mass index and larger waist circumference had a higher risk for bladder ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Colorado Buffaloes head football coach Deion Sanders disclosed his ...
NEW YORK – Digital pathology firm Artera and diagnostics developer Photocure announced on Monday that they will partner for a joint evaluation of a multimodal artificial intelligence-based test for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results